Cargando…
Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response
The targeted delivery of messenger RNA (mRNA) to desired organs remains a great challenge for in vivo applications of mRNA technology. For mRNA vaccines, the targeted delivery to the lymph node (LN) is predicted to reduce side effects and increase the immune response. In this study, we explored an e...
Autores principales: | Chen, Jinjin, Ye, Zhongfeng, Huang, Changfeng, Qiu, Min, Song, Donghui, Li, Yamin, Xu, Qiaobing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407666/ https://www.ncbi.nlm.nih.gov/pubmed/35969778 http://dx.doi.org/10.1073/pnas.2207841119 |
Ejemplares similares
-
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
por: Qiu, Min, et al.
Publicado: (2022) -
Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs
por: Li, Yamin, et al.
Publicado: (2022) -
Elicitation of stem-like CD8(+) T cell responses via lymph node-targeted chemoimmunotherapy evokes systemic tumor control
por: Manspeaker, Margaret P, et al.
Publicado: (2022) -
In situ cancer vaccination using lipidoid nanoparticles
por: Chen, Jinjin, et al.
Publicado: (2021) -
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
por: Yu, Xiang, et al.
Publicado: (2020)